The newly expanded agreement introduces radiation therapy treatment plan validation and care navigation to enrich member care
MORRISVILLE, N.C.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that a leading nonprofit multi-state health plan serving government-sponsored programs, signed a multi-year renewal using the NantHealth Eviti Connect for Oncology platform. The agreement significantly expands the services and functionality beyond the current medical oncology offering to facilitate evidence-based radiation oncology care and better the member experience.
Eviti Connect for Oncology has empowered oncology practices and health plans to prescribe and reimburse high-quality, high-value care for over ten years. The automated process reduces the administrative burdens associated with obtaining and providing authorizations and ensures appropriate reimbursement, aligning payers and providers in their members’ best interests.
“We are very excited to extend this services arrangement and drive enhanced value for our customer, its provider network and their members fighting cancer,” said Ron Louks, chief operating officer at NantHealth. “Building upon the success of our current program, this service expansion will help our health plan customer further its mission of supporting the highest quality patient-centric care.”
The agreement covers over two million members across six states and expands services to include:
- Radiation Therapy – Equipping radiation oncologists with radiation therapy validation using Eviti Connect for Oncology’s comprehensive database of nationally recognized radiation therapies, expanding assurance of evidence-based medicine to the additional 20% of members who require radiation treatment.
- Care Navigation – Offering care navigation capabilities to members going through cancer treatment, guiding members through each step of the treatment journey, eliminating barriers to medication adherence, follow-up appointments, and diminishing caregiver and provider burdens.
- Delegated Entity Services – Prior authorization determinations for treatment, and related provider and member communications, will be delegated to NantHealth, greatly reducing administrative time and costs typically associated with processing determinations.
- Application Programming Interface (API) Connections – Simplifying workflows by customizing systems to receive member treatment plan data directly from the Eviti Connect for Oncology platform, improving access to real-time data and reducing member care delays.
NantHealth’s Eviti Connect is a software-as-a-service (SaaS), evidence-based decision support and treatment plan validation platform that gives providers and payers confidence to prescribe and reimburse high-quality, high-value care. It has helped payers and providers navigate the complexities of cancer care and autoimmune diseases to save time on appeals and expedite optimal patient care while managing payer costs.
For more information about Eviti Connect, visit the NantHealth website.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth’s product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). The OpenNMS Group, Inc., a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook, LinkedIn and YouTube, and subscribe to our blog.
NantHealth Forward Looking Statement
This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate a complex learning system to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; our ability to grow the market for our software and data solutions; successfully enhancing our software and data solutions to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; bandwidth limitations; our ability to integrate The OpenNMS Group, Inc. into our operations; our use and distribution of open source software; our ability to obtain necessary regulatory approvals, certifications and licenses; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.
Contacts
Jen Hodson
NANT
Jen@nant.com
562-397-3639
